Pharming Promises and risks of biopharmaceuticals derived from genetically modified plants and animals /

• Κύριοι συγγραφείς: Rehbinder, Eckard (Συγγραφέας), Rehbinder, E. (Συγγραφέας), Engelhard, M. (Συγγραφέας), Hagen, K. (Συγγραφέας), Jørgensen, R. B. (Συγγραφέας), Pardo-Avellaneda, R. (Συγγραφέας), Schnieke, A. (Συγγραφέας), Thiele, F. (Συγγραφέας)
• Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
• Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
• Γλώσσα: English
• Έκδοση: Berlin, Heidelberg : Springer Berlin Heidelberg, 2009.
• Σειρά: Ethics of Science and Technology Assessment, Schriftenreihe der Europäischen Akademie zur Erforschung von Folgen wissenschaftlich-technischer Entwicklungen Bad Neuenahr-Ahrweiler GmbH, 35
• Θέματα: Medicine.; Pharmacology.; Biochemical engineering.; Ethics.; Biomedical engineering.; Biomedicine.; Pharmacology/Toxicology.; Biochemical Engineering.; Biomedical Engineering.

Recent scientific advances have made it possible to produce biopharmaceuticals in genetically modified plants and animals, such as maize, tobacco, goats, and chickens. This new branch of biotechnology is termed pharming, composed of the terms pharmaceuticals and farming. Pharming constitutes an over...

Πίνακας περιεχομένων:

• The technology of pharming
• Risk assessment of plant pharming and animal pharming
• The welfare of pharming animals
• Public views and attitudes to pharming
• The ethical evaluation of pharming
• The role of patents in the development of pharming
• Legal problems of pharming
• Conclusions and recommendations.